TCOV
ABMD

Trust Company of Vermont’s Abiomed Inc ABMD Stock Holding History

Trust Company of Vermont’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$2K – 806
2021
Q1 		$2K Buy
+6
New +$1.92K ﹤0.01% 730
2016
Q4 		– Sell
-15
Closed -$2K – 949
2016
Q3 		$2K Buy
+15
New +$1.8K ﹤0.01% 797

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Trust Company of Vermont's ABMD Position: Q2 2021 in Review

Trust Company of Vermont sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 6 shares — an estimated $2K sold.

Trust Company of Vermont first reported a position in ABMD in Q3 2016 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Trust Company of Vermont reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Trust Company of Vermont sold 6 Abiomed Inc shares in Q2 2021, an estimated $2K.
  • Trust Company of Vermont first reported a position in Abiomed Inc in Q3 2016 and held it in 2 quarters.
  • Trust Company of Vermont's Abiomed Inc position peaked at $2K in Q1 2021.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Trust Company of Vermont's 13F filing for Q2 2021, filed 15 Jul 2021.